[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368424-105":59,"doc-detail-368424-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","pan-cancer-multi-omics-analysis-to-identify-the-potential-pro-oncogenic-properties-of-grem1-as-a-promising-targets-for-cancer-prognosis-and-therapeutics-abstract","Pan-cancer multi-omics analysis to identify the potential pro-oncogenic properties of GREM1 as a promising targets for cancer prognosis and therapeutics - Abstract","","The study investigates the potential pro-oncogenic properties of GREM1 using pan-cancer multi-omics analysis. GREM1 is examined for links to cancer biology and its unclear mechanisms. GREM1 mRNA expression is extracted from GTEx and TCGA, and prognostic performance is assessed using OS, PFI, DSS, and ROC analyses across cancers. TIMER evaluates associations with immune cell infiltration, while KEGG/GO and STRING-supported PPI networks characterize molecular events. Western blot and BMP-related in vitro experiments test protein changes and effects on migration and proliferation, supporting GREM1 as a promising prognostic biomarker.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-multi-omics-analysis-to-identify-the-potential-pro-oncogenic-properties-of-grem1-as-a-promising-targets-for-cancer-prognosis-and-therapeutics-abstract/368424/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-multi-omics-analysis-to-identify-the-potential-pro-oncogenic-properties-of-grem1-as-a-promising-targets-for-cancer-prognosis-and-therapeutics-abstract/368424.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the pan-cancer multi-omics analysis in this study?","Question",{"text":112,"@type":113},"To investigate the potential pro-oncogenic properties of GREM1 and evaluate its value as a target for cancer prognosis and therapeutics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources and statistical outputs are used to assess GREM1 prognostic value?",{"text":117,"@type":113},"GREM1 mRNA expression is taken from GTEx and TCGA, and prognostic analyses use OS, PFI, DSS, and ROC metrics across multiple cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the study analyze immune involvement and molecular mechanisms for GREM1?",{"text":121,"@type":113},"It uses TIMER to examine immune cell infiltration correlations, KEGG and GO for related molecular pathways, and STRING to construct a PPI network for GREM1-associated events.",{"name":123,"@type":110,"acceptedAnswer":124},"What do the in vitro experiments suggest about BMP regulation of GREM1?",{"text":125,"@type":113},"BMP agonist decreases GREM1 protein levels and suppresses migration and proliferation in GES-1 and BGC cells, while BMP inhibitor promotes GREM1 expression and migration in BGC cells but not in GES-1 cells.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},368424,1790310918,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Pan-cancer multi-omics analysis to identify the potential pro-oncogenic properties of GREM1 as a promising targets for cancer prognosis and therapeutics  \nInternational Journal of Immunopathology and Pharmacology Volume 39: 1–15  \n© The Author(s) 2025  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03946320251331850](DOI: 10.1177/03946320251331850)[ ](DOI: 10.1177/03946320251331850)[journals.sagepub.com/home/iji](journals.sagepub.com/home/iji)  \nMenglu Zhu 1*, Hengli Zhou 1*, Yue Zhuo 1*, Changhua Liu 1, Jiaxin Li 1, Peiyao He 1, Naihua Liu 1, Ziming Zhao2  \nand Pan Huafeng 1,3  \nAbstract  \nWe aimed to investigate the potential pro-oncogenic properties of GREM1 by Pan-cancer multi-omics analysis. Accumulating evidence has highlighted that GREM1 (Gremlin 1), serves as an inhibitor of BMP (Bone Morphogenetic Protein) family, involve in bone related diseases, carcinogenesis, cell stemness, and cell differentiation. However, the effect and underlying mechanism of GREM1 on the cancer biology remain largely elusive. The mRNA expression of GREM1 were extracted from GTEx (Genotype-Tissue Expression) and TCGA (The Cancer Genome Atlas) database. Analysis of OS (Overall Survival), PFI (Progression Free Interval), DSS (Disease-Specific Survival), and ROC (Receiver Operating Characteristic) were performed to predicted prognostic value of GREM1 in various cancers. The TIMER (Tumor Immune Estimation Resource) online tool was used to investigate the relationship between GREM1 transcriptional level and infiltration of immune cells. KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis and GO (Gene Ontology) analysis were used to investigate the GREM1 related molecular events, and then constructed a PPI (Protein-Protein Interaction) network via the STRING (Search Tool for the Retrieval of Interaction Genes/Proteins) online tool. Western blot was performed to investigate the indicated protein expression. In the present study, our results showed that GREM1 tended to be upregulated in various cancers, which would correlate with the poor prognosis. Mechanistically, our results showed that GREM1 involve in regulating the ECM-receptor interaction pathway, upregulation of MMP activity, angiogenesis, and immune cell infiltration. In vitro studies, our results further showed that BMP agonist significantly decreased the protein level of GREM1 in GES-1 cells and BGC cells, which accompanied by inhibiting migration and proliferation in GES-1 cells and BGC cells. BMP inhibitor significantly promoted GREM1 expression and migration in BGC cells, but not GES-1 cells. GREM1 might serve as a potential and promising prognostic biomarker for drug development and cancer treatment.  \nKeywords  \nGremlin 1, migration, pan-cancer, prognosis, proliferation  \nDate received: 17 September 2024; accepted: 16 March 2025  \n1 Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China  \n2Guangdong Province Engineering Technology Research Institute of T.C.M, Guangzhou, China  \n3Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, China  \n*These authors made equal contributions in this work.  \nCorresponding author:  \nPan Huafeng, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, No. 12 Airport Road, Baiyun District, Guangzhou 510006, China.  \nEmail: [gzphf@gzucm.edu.cn](gzphf@gzucm.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([","cbCaidPkN9fmyEKJ","https://ap.wps.com/l/cbCaidPkN9fmyEKJ","pdf",2584732,15,"English","# Abstract\n# Introduction\n## Background on cancer burden and treatment outcomes\n## Prior research on GREM1 in tumor biology","[{\"question\":\"What is the main goal of the pan-cancer multi-omics analysis in this study?\",\"answer\":\"To investigate the potential pro-oncogenic properties of GREM1 and evaluate its value as a target for cancer prognosis and therapeutics.\"},{\"question\":\"Which data sources and statistical outputs are used to assess GREM1 prognostic value?\",\"answer\":\"GREM1 mRNA expression is taken from GTEx and TCGA, and prognostic analyses use OS, PFI, DSS, and ROC metrics across multiple cancers.\"},{\"question\":\"How does the study analyze immune involvement and molecular mechanisms for GREM1?\",\"answer\":\"It uses TIMER to examine immune cell infiltration correlations, KEGG and GO for related molecular pathways, and STRING to construct a PPI network for GREM1-associated events.\"},{\"question\":\"What do the in vitro experiments suggest about BMP regulation of GREM1?\",\"answer\":\"BMP agonist decreases GREM1 protein levels and suppresses migration and proliferation in GES-1 and BGC cells, while BMP inhibitor promotes GREM1 expression and migration in BGC cells but not in GES-1 cells.\"}]","Pan-cancer multi-omics analysis to identify the potential pro-oncogenic properties of GREM1 as a promising targets for cancer prognosis and therapeutics - Abstract | PDF",1790176884,38,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d135a69063246a9f2351922b04d5192a.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd067bc0b837bef12f4e8533a59759c6.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d354e6eb3dc778f76ce9fe77263edf6.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c46da0a1bb557e5350e9a5a2ff285029.webp",980,1306]